Markku K.
- Country
- Finland
- Department
- #3303:Department of Internal Medicine, Rheumatology Unit
Research Overview
Data & Insights
Has run more than one trial at 0 of 68 partner sites.
Specializations
Oncology Therapeutics
The investigator engages in clinical studies targeting solid tumors, emphasizing targeted and endocrine strategies.
- Evaluation of breast cancer treatments integrating cell cycle inhibition
- Assessment of resectability and survival outcomes in metastatic colorectal cancer
These efforts aim to refine therapeutic options for patients with advanced malignancies.
Rheumatology and Immune-Mediated Diseases
Focus is placed on inflammatory and autoimmune conditions, exploring biologic modulation and disease activity control.
- Investigation of giant cell arteritis management with combined glucocorticoid tapering
- Testing of novel agents in systemic lupus erythematosus to reduce disease activity
- Therapeutic trials in ulcerative colitis and crohn's disease using advanced biologics
The work supports optimized care pathways for chronic inflammatory disorders.
Neurocognitive Prevention
Research addresses the mitigation of age‑related cognitive decline through immunization strategies.
- Impact of recombinant zoster vaccine on the incidence of dementia in older adults
This line of inquiry explores preventive measures for neurodegenerative risk.
Diagnostic Imaging in Acute Abdomen
Clinical evaluation of imaging modalities seeks to improve diagnostic accuracy in patients with compromised renal function.
- Comparison of intravenous contrast computed tomography versus native CT for acute abdominal assessment
The objective is to define optimal imaging strategies while safeguarding renal health.
Microbiome‑Based Therapeutic Strategies
Investigation of gut microbiota manipulation as an adjunct to established biologic therapies in inflammatory bowel disease.
- Efficacy of fecal microbiota transplantation combined with anti‑TNF agents
- Safety and microbiota changes when fecal microbiota transplantation is added to integrin‑targeted therapy
These studies aim to integrate microbial modulation into standard treatment regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.